Rational design of novel glycomimetics: inhibitors of concanavalin A.
Karen T Welch, Trent A Turner, Callie E Preast
Index: Bioorg. Med. Chem. Lett. 18 , 6573-5, (2008)
Full Text: HTML
Abstract
A virtual screening approach was used to identify new glycomimetics. The National Cancer Institute Diversity Set was docked into the carbohydrate binding site of the lectin concanavalin A (ConA). The resulting poses were analyzed and 19 molecules were tested for inhibition with an enzyme-linked lectin assay (ELLA). Eight of the 19 molecules inhibited ConA-carbohydrate binding. The two most potent inhibitors have IC(50) values that are an order of magnitude smaller than the monosaccharide methyl alpha-D-mannopyranoside.
Related Compounds
Related Articles:
2011-05-01
[Bioorg. Med. Chem. 19 , 2879-87, (2011)]
2005-06-02
[Bioorg. Med. Chem. Lett. 15 , 2707-10, (2005)]
2007-12-01
[Antimicrob. Agents Chemother. 51 , 4492-4, (2007)]
2012-01-15
[Bioorg. Med. Chem. 20 , 641-9, (2012)]
1979-03-01
[J. Infect. Dis. 139 , 329-32, (1979)]